1. Home
  2. RPID vs NXDT Comparison

RPID vs NXDT Comparison

Compare RPID & NXDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPID
  • NXDT
  • Stock Information
  • Founded
  • RPID 2006
  • NXDT 2012
  • Country
  • RPID United States
  • NXDT United States
  • Employees
  • RPID N/A
  • NXDT N/A
  • Industry
  • RPID Medical Specialities
  • NXDT Investment Managers
  • Sector
  • RPID Health Care
  • NXDT Finance
  • Exchange
  • RPID Nasdaq
  • NXDT Nasdaq
  • Market Cap
  • RPID 138.9M
  • NXDT 187.7M
  • IPO Year
  • RPID 2021
  • NXDT N/A
  • Fundamental
  • Price
  • RPID $3.49
  • NXDT $4.34
  • Analyst Decision
  • RPID Buy
  • NXDT
  • Analyst Count
  • RPID 1
  • NXDT 0
  • Target Price
  • RPID $8.00
  • NXDT N/A
  • AVG Volume (30 Days)
  • RPID 84.2K
  • NXDT 133.6K
  • Earning Date
  • RPID 08-01-2025
  • NXDT 01-01-0001
  • Dividend Yield
  • RPID N/A
  • NXDT 9.66%
  • EPS Growth
  • RPID N/A
  • NXDT N/A
  • EPS
  • RPID N/A
  • NXDT 0.99
  • Revenue
  • RPID $29,645,000.00
  • NXDT N/A
  • Revenue This Year
  • RPID $18.54
  • NXDT N/A
  • Revenue Next Year
  • RPID $20.55
  • NXDT N/A
  • P/E Ratio
  • RPID N/A
  • NXDT $6.41
  • Revenue Growth
  • RPID 28.36
  • NXDT N/A
  • 52 Week Low
  • RPID $0.58
  • NXDT $5.89
  • 52 Week High
  • RPID $4.04
  • NXDT $13.07
  • Technical
  • Relative Strength Index (RSI)
  • RPID 54.22
  • NXDT 59.15
  • Support Level
  • RPID $3.41
  • NXDT $3.80
  • Resistance Level
  • RPID $3.62
  • NXDT $4.53
  • Average True Range (ATR)
  • RPID 0.24
  • NXDT 0.18
  • MACD
  • RPID -0.03
  • NXDT 0.02
  • Stochastic Oscillator
  • RPID 62.03
  • NXDT 56.16

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

About NXDT NexPoint Diversified Real Estate Trust

NexPoint Diversified Real Estate Trust is a publicly traded REIT focused on opportunistic real estate investments in the United States. Their portfolio includes diverse commercial properties and investments across various real estate sectors and capital structures. The revenue sources of the company include rental income from office and retail properties, interest income from debt investments, dividend income from equity investments, and other ancillary income from tenants. The company operates through its operating partnership and wholly owned subsidiaries.

Share on Social Networks: